We addressed the clinical significance of antiproteinase 3 (anti-PR3) antib
ody (Ab) positivity by reviewing the files of 79 patients whose serum conta
ined antineutrophil cytoplasmic antibodies with a cytoplasmic staining patt
ern (cANCA) and had been tested for anti-PR3 reactivity, Vasculitis was pre
sent in most (22/35) cANCA(+) PR3(+) patients but in only a few (5/44) cANC
A(+) PR3(-) patients, thereby suggesting that anti-PR3 Ab positivity in cAN
CA(+) patients is more indicative of vasculitis than cANCA positivity alone
. Noteworthy, one-third of cANCA(+) PR3(+) patients - those with anti-PR3 A
b titres lower than 100 U/ml - did not suffer from vasculitis. Anti-PR3 rea
ctivity in vasculitis patients was only weakly associated with Wegener's gr
anulomatosis (WG), as nine out of 22 cANCA(+) PR3(+) vasculitis patients (4
1%) did not fulfil the ACR classification criteria for WG. There was no cor
relation between anti-PR3 Ab titres and disease activity at diagnosis. Howe
ver, titres measured when patients were in remission were much lower than i
nitial values. Taken together, our results indicate that anti-PR3 Ab positi
vity should be interpreted in its clinical context.